Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
15.69
+0.62 (4.11%)
Aug 4, 2026, 10:10 AM EDT - Market open
Cellebrite DI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 496.43 | 475.68 | 401.2 | 325.11 | 270.65 | 246.25 | |
Revenue Growth | 18.43% | 18.56% | 23.41% | 20.12% | 9.91% | 26.34% |
Cost of Revenue | 80.1 | 75.17 | 62.59 | 53.23 | 50.75 | 42.56 |
Gross Profit | 416.33 | 400.5 | 338.61 | 271.88 | 219.91 | 203.69 |
Selling, General & Admin | 230.52 | 220.15 | 183.29 | 154.26 | 138.24 | 124.33 |
Research & Development | 122.47 | 113.88 | 98.42 | 84.39 | 80.62 | 65.54 |
Total Operating Expenses | 352.99 | 334.02 | 281.7 | 238.64 | 218.86 | 189.87 |
Operating Income | 63.33 | 66.48 | 56.91 | 33.24 | 1.04 | 13.82 |
Interest Income | 21.65 | 24.2 | -332.89 | -108.8 | 119.72 | 68.48 |
Total Non-Operating Income (Expense) | 21.65 | 24.2 | -332.89 | -108.8 | 119.72 | 68.48 |
Pretax Income | 84.98 | 90.68 | -275.98 | -75.56 | 120.76 | 82.31 |
Provision for Income Taxes | 13.12 | 12.35 | 7.02 | 5.54 | -0.05 | 10.91 |
Net Income | 71.86 | 78.33 | -283.01 | -81.1 | 120.81 | 71.4 |
Net Income to Common | 71.86 | 78.33 | -283.01 | -81.1 | 120.81 | 71.4 |
Net Income Growth | - | - | - | - | 69.20% | 1135.01% |
Shares Outstanding (Basic) | 244 | 242 | 209 | 190 | 183 | 144 |
Shares Outstanding (Diluted) | 251 | 250 | 209 | 190 | 195 | 162 |
Shares Change | 10.97% | 19.30% | 10.16% | -2.68% | 20.96% | 30.59% |
EPS (Basic) | 0.29 | 0.32 | -1.35 | -0.43 | 0.64 | 0.49 |
EPS (Diluted) | 0.28 | 0.31 | -1.35 | -0.43 | 0.59 | 0.44 |
EPS Growth | - | - | - | - | 34.09% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 158.62 | 160.32 | 123.61 | 96.83 | 13.68 | 30.94 |
Free Cash Flow Growth | 18.73% | 29.70% | 27.66% | 607.80% | -55.79% | -48.71% |
Free Cash Flow Per Share | 0.63 | 0.64 | 0.59 | 0.51 | 0.07 | 0.19 |
Gross Margin | 83.86% | 84.20% | 84.40% | 83.63% | 81.25% | 82.72% |
Operating Margin | 12.76% | 13.98% | 14.18% | 10.22% | 0.39% | 5.61% |
Profit Margin | 14.48% | 16.47% | -70.54% | -24.95% | 44.64% | 28.99% |
FCF Margin | 31.95% | 33.70% | 30.81% | 29.78% | 5.05% | 12.57% |
EBITDA | 79.57 | 78.35 | 67.51 | 43.25 | 10.24 | 20.83 |
EBITDA Margin | 16.03% | 16.47% | 16.83% | 13.30% | 3.78% | 8.46% |
EBIT | 63.33 | 66.48 | 56.91 | 33.24 | 1.04 | 13.82 |
EBIT Margin | 12.76% | 13.98% | 14.18% | 10.22% | 0.39% | 5.61% |
Effective Tax Rate | 15.44% | 13.62% | -2.54% | -7.33% | -0.04% | 13.25% |